Halifax Biomedical Inc. Opens US Office in Cambridge, Massachusetts
January 28, 2014

Halifax Biomedical Inc. Opens US Office in Cambridge, Massachusetts

Cambridge MA and Halifax, Nova Scotia – January 27, 2014 – Halifax Biomedical Inc. (HBI), a Nova Scotia based company that specializes in precision assessment of spine and joint-replacement micro-instability, is pleased to announce the opening of its first US office at the Cambridge Innovation Center in Cambridge, Massachusetts. The opening of Halifax’s new location follows a recent trade mission to Canada by Massachusetts Governor Deval Patrick.

“Boston is home to several of the best orthopaedic spine research hospitals in the United States,” said Chad Munro, CEO of Halifax Biomedical. “With our expanding International customer base and plans for a multi-center clinical validation of our spine diagnostics, the time to open a US location was right and Boston was the best location to center this growth. There is growing pressure from payors for evidence to support orthopaedic surgical interventions. This has resulted in an increased demand for our technology. In particular our spine diagnostics, which can help provide better pre-operative information for spine treatment decisions.”

“Thanks to our growth strategy of investing in education, innovation and infrastructure, Massachusetts continues to lead the world in life sciences,” said Governor Deval Patrick. “We welcome Halifax Biomedical Inc. to Massachusetts and look forward to their contributions to our thriving life sciences community.”

“On behalf of the Center, I would like to extend our warmest congratulations to Halifax Biomedical Inc. as they open their first U.S. Office here in Massachusetts,” said Susan Windham Bannister, Ph.D., President and CEO of the Massachusetts Life Sciences Center, the agency charged with implementing Governor Patrick’s 10-year, $1 billion Life Sciences Initiative. The Center has been in dialogue with Halifax Biomedical as the company developed their plans for US expansion. “The Commonwealth has a strong diagnostics sector, and a technology-oriented workforce that will provide a depth of talent for Halifax Biomedical as they grow their business here.”

The Massachusetts location will allow HBI to more effectively work with its financial partners and customers as well as the FDA as its products move through the approval process.

Halifax Biomedical Inc
Halifax Biomedical Inc. (HBI) is an evidence-based orthopaedic diagnostics company headquartered in Nova Scotia, Canada with US offices located in Cambridge, MA.

HBI is a world leading provider of micro-instability assessment services using very precise proprietary Stereo Radiography (SR) imaging technology (HALIFAX exams).

HBI focuses on two clinical problems; detection of implant loosening for total hip and knee replacements, and quantification of instability of the spinal column in patients with chronic low back pain.

For more information, please visit www.apps.halifaxbiomedical.com, or contact:

John Simon, COO
Email: john.simon@apps.halifaxbiomedical.com
Office: (902) 945-2771
Fax: (902) 945-2324

Mailing Address:
Halifax Biomedical Inc.
1 Broadway, 14th Floor
Cambridge, MA 02142 USA

Angus G. McQuilken
Vice President for Communications & Marketing
Massachusetts Life Sciences Center